Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cerilliant
Mallinckrodt
Boehringer Ingelheim
Moodys
Baxter
Argus Health
Teva
Daiichi Sankyo

Generated: November 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204507

« Back to Dashboard

NDA 204507 describes FEXOFENADINE HYDROCHLORIDE HIVES, which is a drug marketed by Dr Reddys Labs Ltd, Mylan, Sciegen Pharms Inc, Sun Pharm Inds, Teva, and Wockhardt Ltd, and is included in six NDAs. It is available from ninety-two suppliers. Additional details are available on the FEXOFENADINE HYDROCHLORIDE HIVES profile page.

The generic ingredient in FEXOFENADINE HYDROCHLORIDE HIVES is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and thirteen suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.
Summary for 204507
Tradename:FEXOFENADINE HYDROCHLORIDE HIVES
Applicant:Sciegen Pharms Inc
Ingredient:fexofenadine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 204507
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 204507 ANDA Walgreens 0363-0904 0363-0904-05 5 BLISTER PACK in 1 CARTON (0363-0904-05) > 1 TABLET, COATED in 1 BLISTER PACK
FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 204507 ANDA Walgreens 0363-0904 0363-0904-15 15 BLISTER PACK in 1 CARTON (0363-0904-15) > 1 TABLET, COATED in 1 BLISTER PACK

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength60MG
Approval Date:Sep 16, 2015TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength180MG
Approval Date:Sep 16, 2015TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength60MG
Approval Date:Sep 16, 2015TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chubb
Deloitte
Cipla
Merck
Express Scripts
McKinsey
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.